Aurinia Pharmaceuticals Inc
NASDAQ:AUPH

Watchlist Manager
Aurinia Pharmaceuticals Inc Logo
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Watchlist
Price: 15.62 USD 2.02%
Market Cap: 2.1B USD

Intrinsic Value

The intrinsic value of one AUPH stock under the Base Case scenario is 12.63 USD. Compared to the current market price of 15.62 USD, Aurinia Pharmaceuticals Inc is Overvalued by 19%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

AUPH Intrinsic Value
12.63 USD
Overvaluation 19%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Aurinia Pharmaceuticals Inc

What is Valuation History?
Ask AI Assistant
What other research platforms think about AUPH?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is AUPH valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Aurinia Pharmaceuticals Inc.

Explain Valuation
Compare AUPH to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about AUPH?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Aurinia Pharmaceuticals Inc

Current Assets 438.7m
Cash & Short-Term Investments 351.5m
Receivables 30.7m
Other Current Assets 56.5m
Non-Current Assets 88.8m
PP&E 84.8m
Intangibles 3.9m
Other Non-Current Assets 93k
Current Liabilities 76.2m
Accounts Payable 2.2m
Accrued Liabilities 49.2m
Other Current Liabilities 24.8m
Non-Current Liabilities 85.5m
Long-Term Debt 55.7m
Other Non-Current Liabilities 29.8m
Efficiency

Free Cash Flow Analysis
Aurinia Pharmaceuticals Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Aurinia Pharmaceuticals Inc

Revenue
265.8m USD
Cost of Revenue
-29.4m USD
Gross Profit
236.4m USD
Operating Expenses
-149.4m USD
Operating Income
87m USD
Other Expenses
-9.2m USD
Net Income
77.8m USD
Fundamental Scores

AUPH Profitability Score
Profitability Due Diligence

Aurinia Pharmaceuticals Inc's profitability score is 52/100. The higher the profitability score, the more profitable the company is.

Exceptional ROIC
ROIC is Increasing
ROE is Increasing
Exceptional Gross Margin
52/100
Profitability
Score

Aurinia Pharmaceuticals Inc's profitability score is 52/100. The higher the profitability score, the more profitable the company is.

AUPH Solvency Score
Solvency Due Diligence

Aurinia Pharmaceuticals Inc's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Negative Net Debt
High Altman Z-Score
Low D/E
81/100
Solvency
Score

Aurinia Pharmaceuticals Inc's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

AUPH Price Targets Summary
Aurinia Pharmaceuticals Inc

Wall Street analysts forecast AUPH stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for AUPH is 17.05 USD with a low forecast of 13.13 USD and a high forecast of 22.05 USD.

Lowest
Price Target
13.13 USD
16% Downside
Average
Price Target
17.05 USD
9% Upside
Highest
Price Target
22.05 USD
41% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Aurinia Pharmaceuticals Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for AUPH is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

AUPH Insider Trading
Buy and sell transactions by insiders

AUPH News

What is the Intrinsic Value of one AUPH stock?

The intrinsic value of one AUPH stock under the Base Case scenario is 12.63 USD.

Is AUPH stock undervalued or overvalued?

Compared to the current market price of 15.62 USD, Aurinia Pharmaceuticals Inc is Overvalued by 19%.

Back to Top